Wall St. dips at open as U.S.-North Korea summit ends early
February 28, 2019
Celgene slumps as Bristol-Myers shareholder resists merger
February 28, 2019

Starboard to vote against Bristol-Myers-Celgene $74 billion deal

Activist investor Starboard Value LP will vote against Bristol-Myers Squibb Co’s $74 billion acquisition of Celgene Corp, the hedge fund said on Thursday, adding to the number of shareholders declaring against the deal.

Powered by WPeMatico